Breathe Well Live Well
|
New Data From GAP Landmark Trial Confirm GRAZAX® Prevents Asthma Symptoms in Children
PR Newswire (press release) The data, presented at the 2016 Annual Congress of the European Academy of Allergy and Clinical Immunology (EAACI) in Vienna, confirm that GRAZAX® can prevent asthma symptoms, as well as offering sustained relief from grass allergy symptoms. |
View full post on asthma – Google News
|
New Data From GAP Landmark Trial Confirm GRAZAX® Prevents Asthma Symptoms in Children
PR Newswire UK (press release) ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) today presented new data from the GRAZAX® Asthma Prevention (GAP) trial with GRAZAX®, ALK's allergy immunotherapy tablet against grass pollen allergy. The data, presented at the 2016 Annual Congress … |
View full post on asthma – Google News
|
ALK's Grazax in five-year landmark asthma prevention trial in children sees …
The Pharma Letter (registration) Denmark-based allergy specialist ALK Abello (ALKB: DC) has announced disappointing top-line results from the Grazax Asthma Prevention (GAP) trial with ALK's allergy immunotherapy tablet against grass pollen allergy. The GAP trial consisted of a … |
View full post on asthma – Google News
|
ALK announces top-line results from the five-year landmark GRAZAX® Asthma …
GlobeNewswire (press release) The trial did not show an effect in terms of time to first diagnosis of reversible impairment of lung function. The trial demonstrated that GRAZAX® treatment significantly reduced the proportion of children experiencing asthma symptoms or using asthma … BRIEF-Alk Abello announces results from GRAZAX Asthma Prevention trial in children ALK announces top-line results from the five-year landmark GRAZAX(r) Asthma … |
View full post on asthma – Google News
|
ALK announces top-line results from the five-year landmark GRAZAX(r) Asthma …
EconoTimes In contrast, treatment with GRAZAX(r) had a positive effect on the children's asthma symptoms and use of asthma medication. The odds ratio (secondary endpoint) for experiencing asthma symptoms[1] or using asthma medication[2], at the end of the five … |
View full post on asthma – Google News
|
CDISC and TransCelerate BioPharma Inc. Announce Landmark Asthma Data …
PR Newswire (press release) AUSTIN, Texas, Sept. 18, 2013 /PRNewswire/ — The Clinical Data Interchange Standards Consortium (CDISC) and TransCelerate BioPharma Inc. ("TransCelerate"), are pleased to announce that version 1.0 of the Asthma Therapeutic Area (TA) Data Standard … |
View full post on asthma – Google News
|
Landmark Study Affirms the Clinical Utility of ImmunoCAP Allergy Testing
Insurance News Net (press release) This wealth of information on allergies and asthma in the US was made possible by data collected from Quest Diagnostic's use of the ImmunoCAP Specific IgE blood test from Phadia, the market leading in vitro allergy diagnostic test. … |
View full post on asthma – Google News
 Babble (blog) |
Landmark Study Shows Suboptimal Asthma Care
Medical News Today (press release) Researchers assessed asthma burden and treatment practice in the US based on results of the recently completed Asthma Insight and Management telephone … Health Alerts: anaphylaxis, recalls, depression Allergic to kissing? Cell phones? Bed Bugs? ACAAI: Asthma at Center Stage |
View full post on asthma – Google News